June 7 (Reuters) - FibroGen Inc said on Wednesday its drug for the treatment of a type of neuromuscular disease failed to meet main goal in a late-stage study. (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The $50 million purchase could turn into Nvidia's biggest investment.
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
“When she died, we were told by her attorney that we were responsible for the taxes and property insurance during the time when the life tennant lives in the home.”
These proven wealth builders could be exactly what you're searching for right now.
These three tech stocks look like reliable long-term winners.
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.